Lisa Brockway

How to address barriers to clinical trial patient recruitment [update]

[Updated June 2019]

Continue reading

Webinar Recap: Precision Recruitment

With clinical trial protocols becoming ever more complex, it can feel like it’s never been more difficult to find patients who are both eligible for ...

Continue reading

The Next Phase of Faster Clinical Trial Patient Recruitment

For years, clinical trial patient recruitment has looked the same: identify eligibility criteria for a single trial, conduct traditional media ...

Continue reading

5 Benefits of Faster Clinical Trial Patient Recruitment

One of the most frustrating elements of medical research today is the speed — patients need new treatments now, but often, clinical trials are ...

Continue reading

Antidote and the American Liver Foundation (ALF) announce partnership to accelerate liver disease research

Today, liver disease affects 30 million people in the US — one in 10 Americans. And unfortunately, that number is on the rise. To address this ...

Continue reading

Scrip Awards: Antidote’s Work Connecting Patients to Research Studies is Recognized

If you’ve been diagnosed with an illness, you probably know the accompanying feeling of uncertainty all too well. How will this impact your life? ...

Continue reading

Scrip Awards: Antidote Named as Finalist in Technology and Partnerships Categories

We’ve long followed the Scrip Awards - where the industry’s highest achievers are recognized for outstanding work across the drug development ...

Continue reading

Scrip Awards: JDRF and Antidote Collaborate to Connect Patients to Research Studies

It’s been an exciting fall here at Antidote. We announced our latest round of funding, grew our partner network to more than 210 partners, and are ...

Continue reading

Lupus Research Alliance and Antidote partner to accelerate lupus research

Today, we are pleased to announce a new partnership with the Lupus Research Alliance to help lupus patients and their loved ones find and understand ...

Continue reading

Get our latest posts in your inbox